
- Volume 0 0
Poll Looks at Pseudoephedrine Debate
A consumer survey, commissionedby the National Consumers Leagueand the Food Marketing Institute,explored putting OTC products withpseudoephedrine behind the counter.Although consumers said that they arewilling to tolerate restrictions on buyingpseudoephedrine products, manydo not want OTC products with thatingredient to be available only at pharmacies.
The survey indicated that 62% ofthe respondents believed that keepingpseudoephedrine products in lockeddisplay cases was "somewhat reasonable"or "very reasonable." Yet, 44%said that restricting sales of the coldmedicine ingredient to pharmacieswould create a burden. Of the totalrespondents, 71% supported puttingsuch cough, cold, and allergy productsbehind "a counter, not a pharmacycounter." Restricting the quantity ofsuch products that individuals canpurchase was favored by 84%, andputting an age limit on the buyers wassupported by 74%.
Articles in this issue
over 20 years ago
Antibiotics, Probiotics, and Microfloraover 20 years ago
Calcium: An Essential Mineralover 20 years ago
CAN YOU READTHESE Rxs?over 20 years ago
ECKEL RECEIVES ALUMNI AWARDover 20 years ago
Cancer: Update on Biologicsover 20 years ago
Managing Chronic Pain: An Analysis of the Use of Opioidsover 20 years ago
PHARMACIST'S RIGHT TO CHOOSE?over 20 years ago
Teenage Drug Diversion—Part 2over 20 years ago
Is Altering Refills a Criminal Act?over 20 years ago
Do All SSRIs Interact the Same Way?Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.